Inhibikase Therapeutics, Inc.Share Price
|
|
Share Price & Volume
| Previous Close | $1.95 | |
| Open | 0.00% | $1.95 |
| Day Low | -1.03% | $1.93 |
| Day High | +4.10% | $2.03 |
| 52-Week Low | -31.79% | $1.33 |
| 52-Week High | +32.31% | $2.58 |
| Day Volume | 762,996 | |
| Average Volume | 1,616,981 | |
| EPS (TTM) | $0.47 | |
| P/E (TTM) | 4.30x | |
| FWD P/E (NTM) | - | |
| Next Earnings Date | Mar 26, 2026 |
| Market Cap | 143,425,965 | |
| Shares Outstanding (Millions) | 71,002,953 | |
| Dividend | - | |
| Beta | 0.89 | |
| ROE | -0.98% | |
| ROA | -0.57% |
Analyst Ratings and Price Targets
Current:
$2.02
Average:
$6.00
(+197.03%)
Low:
$4.00
(+98.02%)
High:
$8.00
(+296.04%)
| Ladenburg Thalmann | Initiates Coverage On | Buy | $4.00 | +98.02% | Mar 3, 2026 |
| B of A Securities | Initiates Coverage On | Buy | $6.00 | +197.03% | Jan 21, 2026 |
| HC Wainwright & Co. | Assumes | Buy | $8.00 | +296.04% | Dec 26, 2025 |
Headquarters
Atlanta, GA, USA
Sector
Industry
# of Employees
15